https://www.ema.europa.eu/en/medicines/human/EPAR/hympavzi 2025 false false false Netherlands French English syndication feed summary of product characteristics package leaflet drug evaluation treatment outcome marstacimab marstacimab marstacimab drug approval europe antibodies, monoclonal, humanized antibodies, monoclonal, humanized adolescent adult hemorrhage hemophilia B hemophilia A injections, subcutaneous tissue factor pathway inhibitor risk management product surveillance, postmarketing aged pregnancy breast feeding drug evaluation, preclinical
--- https://www.has-sante.fr/jcms/p_3597499/fr/hympavzi-marstacimab-hemophilie 2025 false false false France hemorrhage evaluation of the transparency committee marstacimab hemophilia A